The Phytochemical Trifolin Found to Protect the Heart Against Hypertension Damage

Herbs and Phytochemicals: Hypertension, commonly known as high blood pressure, has become a serious concern globally. It often leads to a range of heart issues, including cardiac injury due to the breakdown and death of heart cells, known as cardiomyocyte apoptosis. High blood pressure often makes the heart work harder, causing strain that can lead to long-term damage. Researchers from the Academy of Integrative Medicine at Fujian University of Traditional Chinese Medicine and several other institutions in China have been exploring new therapies to address these issues, particularly in preventing cell death in heart muscles.


The Phytochemical Trifolin Found to Protect the Heart Against Hypertension Damage

This Herbs and Phytochemicals news report delves into the latest research on Trifolin, a phytochemical compound derived from plants such as Camptotheca acuminata, Euphorbia condylocarpa or in Consolida oliveriana, and its effects on heart health. Trifolin, a flavonoid, is already known for its potential antioxidant properties. However, its role in heart health and combating hypertension-induced damage was largely unexplored until now.
 
Study Design and Methodology
Researchers created two experimental setups to explore Trifolin’s effects: one involving mice infused with Angiotensin II (AngII) to mimic hypertension, and another using H9C2 heart cells. AngII is a compound often associated with high blood pressure, and its infusion in these models effectively creates a hypertensive environment. The mice were divided into groups, with some receiving varying doses of Trifolin and others receiving Valsartan, a common blood pressure medication, for comparison.
 
The researchers assessed heart function through echocardiography, a technique that visualizes heart performance, and observed tissue samples using various staining methods to evaluate the cellular impact of treatment. Western blotting and other tests were used to analyze protein expression, helping to reveal the molecular mechanisms of Trifolin's effects.
 
Key Findings: Trifolin Improves Heart Function and Reduces Cell Death
The study showed that Trifolin significantly improved heart function in hypertensive mice. With the administration of Trifolin, the left ventricular ejection fraction (LVEF) and fractional shortening - both measures of how effectively the heart pumps blood - were preserved in mice under hypertensive conditions. These improvements indicate that Trifolin can reduce the physical strain that hypertension places on the heart, promoting better overall function.
 
Further observations under the microscope revealed that Trifolin also reduced inflammation and disorganization in heart tissue. Mice treated with Trifolin showed fewer signs of tissue damage and more stable tissue structure, indicating a direct protective effect of the compound on heart muscle cells.
 
Additionally, Trifolin treatment significantly lowered the number of apoptotic (dying) cells in the heart. The researchers note d that in hypertensive conditions, there is an increase in pro-apoptotic proteins like Bax and cleaved caspase-3, along with a decrease in anti-apoptotic protein Bcl-2. Trifolin helped reverse these changes, suggesting that it can effectively curb the cellular processes leading to cell death under stress from high blood pressure.
 
Mechanisms of Trifolin Action: Pathway Insights
To understand how Trifolin provides these protective benefits, the researchers used network pharmacology - a technique that helps identify potential drug targets and biological pathways. They discovered that Trifolin interacts with several important signaling pathways, including the PI3K/AKT, MAPK, and HIF-1 pathways. These pathways are vital in regulating cell survival and apoptosis, particularly in response to stress factors such as high blood pressure.
 
-PI3K/AKT Pathway: This pathway plays a central role in cell survival, often counteracting pro-apoptotic signals to help maintain cellular function. The research showed that Trifolin increased phosphorylation of PI3K and AKT, two key proteins in this pathway, enhancing their cell-protective effects.
 
-MAPK Pathway: Known for its involvement in cell response to stress, the MAPK pathway can drive apoptosis when overactivated. Trifolin was found to reduce the activity of MAPK-associated proteins like ERK, p38 MAPK, and JNK, potentially limiting the pathway's role in triggering cell death.
 
-HIF-1 Pathway: Hypoxia-inducible factor 1 (HIF-1) usually responds to low oxygen levels and is often upregulated in hypertension, contributing to cell death. Trifolin inhibited HIF-1α, a protein in this pathway, indicating its role in modulating hypoxia-related damage.
 
Through these mechanisms, Trifolin appeared to modulate a complex network of cellular responses, tipping the balance away from cell death and toward survival, even in a hypertensive setting.
 
Trifolin's Role in Reducing Mitochondrial Stress
One of the ways that high blood pressure induces damage is by disrupting the mitochondria, the cell's energy powerhouses. Trifolin was shown to help maintain mitochondrial health in hypertensive heart cells by stabilizing mitochondrial membranes, which is crucial in preventing the early stages of apoptosis. This protective effect was evident in tests involving JC-1 staining, a method used to assess mitochondrial health.
 
Comparative Effectiveness of Trifolin vs. Conventional Treatments
In comparing Trifolin with Valsartan, a widely-used blood pressure medication, researchers found that while both treatments provided protective effects, Trifolin uniquely targeted the cellular pathways associated with apoptosis. This suggests that Trifolin could potentially serve as a complementary treatment to conventional blood pressure management by specifically addressing heart muscle preservation.
 
Future Directions and Potential for Trifolin in Hypertensive Patients
While these findings in animal models and cell cultures are promising, further research is needed to confirm Trifolin’s effects in human subjects. Future studies will likely explore the specific dosing and long-term effects of Trifolin in hypertensive patients, particularly in preventing heart failure and other severe cardiac complications associated with long-term high blood pressure.
 
The researchers believe that Trifolin could provide an effective natural alternative or supplement to current treatments, especially for patients at risk of heart failure due to hypertension. By targeting the pathways responsible for cardiomyocyte apoptosis, Trifolin shows promise as a therapeutic agent with the potential to fill a critical gap in hypertension care.
 
Conclusion
Trifolin offers a compelling new approach to treating heart damage caused by hypertension. By preserving heart function and reducing cell death through its impact on the PI3K/AKT, MAPK, and HIF-1 pathways, Trifolin demonstrates a multifaceted protective effect. This study adds valuable insight into how natural compounds like Trifolin could complement existing hypertension treatments, helping to reduce the heart risks associated with high blood pressure.
 
As with any new therapy, further clinical trials are needed to determine the safety and efficacy of Trifolin for humans. If these trials confirm the findings observed in mice and cell cultures, Trifolin could become an important addition to hypertension management, especially for patients who struggle with conventional therapies.
 
The study findings were published in the peer-reviewed European Journal of Pharmacology.
https://www.sciencedirect.com/science/article/pii/S001429992400815X
 
For the latest on Herbs and Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/peptides-from-bitter-melon-as-a-natural-aid-for-diabetes-and-hypertension
 
https://www.thailandmedical.news/news/taiwanese-study-reveals-heart-health-benefits-of-the-phytochemical-momordicine-i-from-bitter-melon